C2i Genomics and Karkinos Healthcare Partner to Bring AI-Powered Cancer Detection and Monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India MUMBAI, 03 JUNE 2022 (GPN): C2i Genomics, a cancer intelligence company, today announced a strategic partnership with…